(Q67476173)

English

Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis

scientific article published on 01 November 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis (English)

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

author name string

P. F. Zangerle

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

D. De Groote

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

M. Lopez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

R. J. Meuleman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

Y. Vrindts

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

F. Fauchet

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

I. Dehart

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

M. Jadoul

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

D. Radoux

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

P. Franchimont

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1292640

10 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1292640

10 September 2022

publication date

1 November 1992

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:104346669290021I?httpAccept=text/xml

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

https://api.elsevier.com/content/article/PII:104346669290021I?httpAccept=text/plain

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

568-575

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs

1

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

T-cell receptors and rheumatic disease: approaches to repertoire analysis

2

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Heberden Oration, 1988. Exploring immune pathways in rheumatoid arthritis

3

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokine expression in rheumatoid arthritis

4

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokines in Rheumatoid Arthritis

5

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Pathophysiology of cytokines.

6

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Mechanisms of matrix degradation in rheumatoid arthritis

7

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis

8

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

9

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokines and anticytokines

12

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Synovial fluid concentration of five different cytokines in rheumatic diseases

16

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis

19

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation

20

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokine production in whole bloodex vivo

21

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages

22

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect

25

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine

28

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Effects of a hydrosoluble bacterial extract from Escherichia coli (OM-89) on cytokine production by peripheral blood mononuclear cells from healthy subjects and patients with rheumatoid arthritis

29

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

In situ hybridization of IL-6 in rheumatoid arthritis

32

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

34

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Purification of human monocytes on microexudate-coated surfaces

35

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides

36

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients

38

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

T lymphocyte adhesion to human synovial fibroblasts. Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18.

40

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Concentration of interleukin-1 beta in serum and synovial fluid in patients with rheumatoid arthritis and those with osteoarthritis

41

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Interleukin-2 inhibitor in rheumatoid arthritis synovial fluid does not inhibit mononuclear cell responses to mitogens

42

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Soluble interleukin-2 receptor in juvenile rheumatoid arthritis

44

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

The soluble interleukin-2 receptor in rheumatic disease

45

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokines in autoimmune diseases

47

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma

48

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Arthritis in patients with psoriasis treated with gamma-interferon

49

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function

50

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

51

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions

52

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

53

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

54

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Biological and clinical aspects of interleukin 6.

55

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

How important are T cells in chronic rheumatoid synovitis?

56

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Cellular basis for rheumatoid inflammation

57

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Methotrexate: mechanism of action in rheumatoid arthritis

58

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Production of cytokines by chondrocytes and its role in proteoglycan degradation

59

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Interleukin-6 in synovial fluid from patients with arthritis

62

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases

63

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage

64

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

65

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

66

1 reference

10.1016/1043-4666(92)90021-I

https://api.crossref.org/works/10.1016/1043-4666(92)90021-I

27 November 2023

Identifiers

10.1016/1043-4666(92)90021-I

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1292640%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67476173&oldid=2018772062"